Long-Term Risk of Skin Cancer and Lymphoma in Users of Topical Tacrolimus and Pimecrolimus: Final Results from the Extension of the Cohort Study Protopic Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (JOELLE)

PURPOSE: Evidence is insufficient to infer whether topical calcineurin inhibitors (TCIs; tacrolimus and pimecrolimus) cause malignancy. The study objective was to estimate the long-term risk of skin cancer and lymphoma associated with topical TCI use in adults and children, separately. PATIENTS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Arana, Alejandro, Pottegård, Anton, Kuiper, Josephina G, Booth, Helen, Reutfors, Johan, Calingaert, Brian, Lund, Lars Christian, Crellin, Elizabeth, Schmitt-Egenolf, Marcus, Kaye, James A, Gembert, Karin, Rothman, Kenneth J, Kieler, Helle, Dedman, Daniel, Houben, Eline, Gutiérrez, Lia, Hallas, Jesper, Perez-Gutthann, Susana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721027/
https://www.ncbi.nlm.nih.gov/pubmed/35002327
http://dx.doi.org/10.2147/CLEP.S331287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721027/
https://www.ncbi.nlm.nih.gov/pubmed/35002327
http://dx.doi.org/10.2147/CLEP.S331287

Ejemplares similares